319 related articles for article (PubMed ID: 19748843)
1. [Guidelines for vitamin D prescription in dialysis patients].
Jean G; Lafage-Proust MH; Massy ZA; Drüeke TB
Nephrol Ther; 2009 Nov; 5(6):520-32. PubMed ID: 19748843
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
[TBL] [Abstract][Full Text] [Related]
4. The dual vitamin D pathways: considerations for adequate supplementation.
Cronin SC
Nephrol Nurs J; 2010; 37(1):19-26, 36; quiz 27-8. PubMed ID: 20333900
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
6. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease.
Kalantar-Zadeh K; Kovesdy CP
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1529-39. PubMed ID: 19661219
[TBL] [Abstract][Full Text] [Related]
9. The impact of routine vitamin supplementation on serum levels of 25 (OH) D3 among the general adult population and patients with chronic kidney disease.
Tareen N; Martins D; Zadshir A; Pan D; Norris KC
Ethn Dis; 2005; 15(4 Suppl 5):S5-102-6. PubMed ID: 16315388
[TBL] [Abstract][Full Text] [Related]
10. [Vitamin D: synthesis, metabolism, regulation, and an assessment of its deficiency in patients with chronic renal disease].
Spustová V; Dzúrik R
Vnitr Lek; 2004 Jul; 50(7):537-43. PubMed ID: 15323262
[TBL] [Abstract][Full Text] [Related]
11. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
Jean G; Souberbielle JC; Chazot C
Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
[TBL] [Abstract][Full Text] [Related]
12. Use of vitamin D in clinical practice.
Cannell JJ; Hollis BW
Altern Med Rev; 2008 Mar; 13(1):6-20. PubMed ID: 18377099
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D treatment in chronic kidney disease.
Andress DL
Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
[TBL] [Abstract][Full Text] [Related]
14. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study.
Tentori F; Albert JM; Young EW; Blayney MJ; Robinson BM; Pisoni RL; Akiba T; Greenwood RN; Kimata N; Levin NW; Piera LM; Saran R; Wolfe RA; Port FK
Nephrol Dial Transplant; 2009 Mar; 24(3):963-72. PubMed ID: 19028748
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D deficiency in kidney transplant recipients: risk factors and effects of vitamin D3 supplements.
Marcén R; Ponte B; Rodríguez-Mendiola N; Fernández-Rodriguez A; Galeano C; Villafruela JJ; Teruel JL; Burgos FJ; Ortuño J
Transplant Proc; 2009; 41(6):2388-90. PubMed ID: 19715928
[TBL] [Abstract][Full Text] [Related]
16. [Role of paracalcitol in the management of non-dialysis CKD: state of art and... Unmet needs].
Mascia S; Garofalo C; Donnarumma G; Di Pietro R; Liberti ME; Pacilio M; Sagliocca A; Zamboli P; Minutolo R; Conte G; De Nicola L
G Ital Nefrol; 2010; 27(6):616-28. PubMed ID: 21132644
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D supplementation in CKD.
Martin KJ; González EA
Clin Nephrol; 2011 Apr; 75(4):286-93. PubMed ID: 21426882
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease.
Oksa A; Spustová V; Krivosíková Z; Gazdíková K; Fedelesová V; Lajdová I; Stefíková K; Bernasovská G; Zilinská Z; Dzúrik R
Kidney Blood Press Res; 2008; 31(5):322-9. PubMed ID: 18802363
[TBL] [Abstract][Full Text] [Related]
19. Hypovitaminosis D in chronic kidney disease patients: prevalence and treatment.
Cuppari L; Garcia-Lopes MG
J Ren Nutr; 2009 Jan; 19(1):38-43. PubMed ID: 19121769
[TBL] [Abstract][Full Text] [Related]
20. [Vitamin D deficiency in CKD patients].
Hamano T
Clin Calcium; 2007 May; 17(5):718-24. PubMed ID: 17471001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
